Table 2.
susceptibility pattern of 20 gram negative isolates from febrile children (N = 317)
| NO | ISOLATE | G | CIP | TET | AK | AMC | NO | C | SXT | A | CZA | CRO | CTX | MEM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
99 |
Escherichia coli |
R |
S |
R |
S |
S |
S |
R |
R |
R |
S |
S |
S |
S |
|
119 |
Escherichia coli |
S |
R |
R |
S |
R |
S |
S |
R |
R |
S |
S |
S |
S |
|
212 |
Escherichia coli |
R |
S |
R |
S |
R |
S |
R |
R |
R |
S |
S |
S |
S |
|
237 |
*Escherichia coli |
R |
R |
R |
S |
R |
R |
S |
R |
R |
R |
R |
R |
S |
|
253 |
Escherichia coli |
S |
S |
R |
S |
S |
S |
R |
R |
S |
S |
S |
S |
S |
|
275 |
Escherichia coli |
R |
S |
R |
S |
R |
S |
R |
R |
R |
S |
S |
S |
S |
|
300 |
Escherichia coli |
R |
R |
R |
S |
R |
S |
R |
R |
R |
S |
S |
S |
S |
|
28 |
K. pnuemoniae |
R |
R |
R |
R |
R |
S |
R |
R |
R |
S |
S |
S |
S |
|
50 |
K. pnuemoniae |
R |
S |
R |
R |
R |
S |
R |
R |
R |
S |
S |
S |
S |
|
101 |
*K. pnuemoniae |
R |
S |
R |
R |
R |
S |
R |
R |
R |
R |
R |
R |
S |
|
189 |
*K. pnuemoniae |
R |
R |
R |
S |
R |
S |
R |
R |
R |
R |
R |
R |
S |
|
255 |
K. pnuemoniae |
R |
S |
R |
R |
R |
S |
R |
R |
R |
S |
S |
S |
S |
|
215 |
K. pnuemoniae |
R |
S |
R |
R |
R |
S |
R |
R |
R |
S |
S |
S |
S |
|
12 |
P.aeuriginosa |
R |
S |
R |
S |
R |
S |
R |
R |
R |
R |
NA |
NA |
S |
|
148 |
P.aeuriginosa |
R |
R |
R |
R |
R |
R |
R |
R |
R |
S |
NA |
NA |
S |
|
21 |
Enterobacter spp |
S |
S |
S |
S |
R |
S |
S |
R |
R |
S |
S |
S |
S |
|
108 |
Salmonella spp |
S |
S |
S |
S |
S |
S |
S |
S |
R |
S |
S |
S |
S |
|
191 |
*Citrobacter spp |
R |
S |
R |
S |
R |
S |
S |
R |
R |
R |
R |
R |
S |
|
250 |
*Citrobacter spp |
R |
S |
R |
S |
R |
S |
S |
R |
R |
R |
R |
R |
S |
|
5 |
Proteus spp |
R |
S |
R |
S |
R |
S |
S |
R |
R |
S |
S |
S |
S |
| 60 | S. aureus | R | R | R | S | R | S | R | R | R | NA | NA | NA | S |
A; ampicillin, AMC; amoxyillin/clavunate, CIP; ciprofloxacin, TET; tetracycline, G; gentamicin, SXT; sulfamethoxazole/ trimethoprim, CRO; ceftriaxone, CAZ; ceftazidime, AK: amikacin, MEM; meropenem, NO; Norfloxacin, C; chloramphenicol and CTX; Cefotaxime. R; resistant, S; sensitive. * ESBL producer, NA; Not applicable, S: Inducible resistance is expected. S; Salmonella spp may test susceptible in vitro but the drug is ineffective in vivo. Isolate no 60 was tested with cefoxitin and oxacillin and found to be sensitive so it is not MRSA.